EUVIMEDEUVIMED entdecken
Crossref

Degradable Multifunctional Microspheres for Combined Thermotherapy‐Embolization‐Immune Activation Therapy of Hepatocellular Carcinoma

Xuepeng Lv, Mingxi Ma, Zhaoyang Zhao, You Li, Jie Kong, Guoqiang Shao, Weiwei Tang, Fei Xiong iD

Advanced Healthcare Materials · 2026-03 · 15 (10)

DOI: 10.1002/adhm.202504261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 17.12.2025. Verfasst von Xuepeng Lv und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Lab of Digital Medical Engineering Jiangsu Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, S…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Microspheres, Hyperthermia, Induced. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province Frontier Technology Research and Development Program, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transarterial chemoembolization (TACE) is the first‐line treatment for unresectable intermediate and advanced hepatocellular carcinoma (HCC). Nevertheless, the upregulation of vascular endothelial growth factor A (VEGF‐A) and the angiogenesis response triggered by the hypoxic environment following embolization can facilitate tumor recurrence. The combination of TAE/TACE and anti‐angiogenic drugs has become one of the important strategies in the treatment of liver cancer. However, anti‐angiogenic strategies using monotherapies that only target VEGF or vascular endothelial growth factor receptor (VEGFR) have limited efficacy in the treatment of HCC. Hence, we designed a degradable embolic microsphere (RegFe@MS) capable of simultaneously loading hydrophobic regorafenib and magnetic iron oxide nanoparticles. Through the “two‐liquid phase sequential drug loading technology”, RegFe@MS can effectively absorb and encapsulate regorafenib like a sponge. It has been shown that RegFe@MS can inhibit the upregulation of HIF‐1α and the expression of CCR6 through mild hyperthermia, thereby suppressing the release of VEGF‐A. In addition, local sustained release of regorafenib can be used to inhibit VEGFR. This strategy can not only inhibit the post‐embolization angiogenic response but also maximally suppress the proliferation and invasion of residual tumors. Furthermore, RegFe@MS has demonstrated remarkable therapeutic effects in the rabbit orthotopic liver cancer model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicrospheresHyperthermia, InducedAnimalsPyridinesHumansPhenylurea CompoundsVascular Endothelial Growth Factor AMiceCell Line, TumorChemoembolization, TherapeuticMale

Stichwörter der Autor:innen

hepatocellular carcinomamagnetic hyperthermia therapymicrospheresregorafenibtransarterial chemoembolization

Substanzen

PyridinesregorafenibPhenylurea CompoundsVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • State Key Lab of Digital Medical Engineering Jiangsu Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, P. R. China.
  • School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
  • State Key Laboratory of Natural Medicines school of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, P. R. China.
  • Department of Intervention, Nanjing First Hospital, Nanjing Medical University, Nanjing, P. R. China.
  • Department of Nuclear Medicine, Nanjing First Hospital, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China.
  • Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, P. R. China.

ORCID-Profile: Fei Xiong

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Province Frontier Technology Research and Development Program
  • National Key Research and Development Program of China

Zitieren

APA

Lv, X., Ma, M., Zhao, Z., Li, Y., Kong, J., Shao, G., Tang, W., & Xiong, F. (2026). Degradable Multifunctional Microspheres for Combined Thermotherapy‐Embolization‐Immune Activation Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials, 15(10). https://doi.org/10.1002/adhm.202504261

Vancouver

Lv X, Ma M, Zhao Z, Li Y, Kong J, Shao G, et al. Degradable Multifunctional Microspheres for Combined Thermotherapy‐Embolization‐Immune Activation Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials. 2026;15(10). doi:10.1002/adhm.202504261

BibTeX
@article{Lv2026,
  author = {Lv, Xuepeng and Ma, Mingxi and Zhao, Zhaoyang and Li, You and Kong, Jie and Shao, Guoqiang and Tang, Weiwei and Xiong, Fei},
  title = {Degradable Multifunctional Microspheres for Combined Thermotherapy‐Embolization‐Immune Activation Therapy of Hepatocellular Carcinoma},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {10},
  doi = {10.1002/adhm.202504261}
}
Kostenlos starten →